For hit selection in genome-scale RNAi research, we do not want to miss small interfering RNAs (siRNAs) with large effects; meanwhile, we do not want to include siRNAs with small or no effects in the list of selected hits. There is a strong need to control both the false-negative rate (FNR), in which the siRNAs with large effects are not selected as hits, and the restricted false-positive rate (RFPR), in which the siRNAs with no or small effects are selected as hits. An error control method based on strictly standardized mean difference (SSMD) has been proposed to maintain a flexible and balanced control of FNR and RFPR. In this article, the authors illustrate how to maintain a balanced control of both FNR and RFPR using the plot of error rate versus SSMD as well as how to keep high powers using the plot of power versus SSMD in RNAi high-throughput screening experiments. There are relationships among FNR, RFPR, Type I and II errors, and power. Understanding the differences and links among these concepts is essential for people to use statistical terminology correctly and effectively for data analysis in genome-scale RNAi screens. Here the authors explore these differences and links. (Journal of Biomolecular Screening 2009:230-238) Key words: restricted false-positive rate, false-negative rate, strictly standardized mean difference, Type I error, Type II error, power INTRODUCTION R NAI IS A MECHANISM THAT KNOCKS DOWN GENES with complementary nucleotide sequences of doublestranded RNA. [1] [2] [3] In genome-scale RNAi screen experiments, the primary interest is (1) the assessment of the magnitude of impact on a biological response related to the knockdown of a gene and (2) the selection of siRNAs with large effects on the biological response of interest. The key is to search an analytic metric to effectively quantify knockdown effect and then to construct a selection criterion based on this metric to control false-positive and false-negative rates. Strictly standardized mean difference (SSMD) has been proposed and adopted for both quality control [4] [5] [6] and assessment of siRNA effects in RNAi high-throughput screening (HTS) assays. [7] [8] [9] [10] Two clear advantages of using SSMD to asses siRNA effects are that (1) SSMD has both an original and probability meaning, and (2) its value is comparable across experiments. 4, 8, 10 Based on SSMD, an error control method has been proposed to maintain a flexible and balanced control of the false-negative rate (FNR), in which the siRNAs with large effects are not selected as hits, and the restricted false-positive rate (RFPR), in which the siRNAs with small or no effects are selected as hits. 8 In this article, we illustrate how to maintain a balanced control of both FNR and RFPR using the plot of error rate versus SSMD cutoff (or critical value) 10 as well as how to keep high powers using the plot of power versus SSMD critical value in RNAi HTS experiments. FNR and RFPR may be linked to Type I and II error rates under certain conditions, and they are also related to statistical power. Understanding the relationship among these concepts is essential for people to use statistical terminology correctly and effectively for data analysis in a genome-scale RNAi screen. Thus, we also explore the relationships among FNR, RFPR, Type I and II errors, and power within the context of selecting hits in RNAi HTS assays.
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ERROR RATES AND POWERS IN GENOME-SCALE RNAi SCREENS
It is well known that cells are controlled by dynamic actions of thousands of genes that are related through a complex interaction. Because of the existence of a gene network, the knockdown of any gene by its corresponding siRNA(s) may affect other genes even though the size of effect may differ. 11 Thus, in a broad sense, there is rarely any siRNA that has exactly no impact on a measured biochemical response, although most siRNAs have small effects in a genome-scale RNAi screen. Therefore, there are 2 major concerns for hit selection in RNAi HTS experiments. First, we do not want the siRNAs with large effects to be selected as nonhits. Second, we do not want the siRNAs with small effects to be selected as hits. The rate in which the siRNAs with small effects are selected as hits is RFPR, and the rate in which the siRNAs with large effects are not selected as hits is FNR. To control RFPR and FNR, we first need a metric effectively measuring the size of siRNA effects. Mean difference, fold change, percent viability, p-value, and other similar measures cannot effectively measure the size of siRNA effects, whereas SSMD effectively measures the size of siRNA effects. 4, 6, 8, 10 SSMD (denoted as b) is defined as the ratio of mean to standard deviation of the difference between the 2 groupsnamely, b = . It has been mentioned recently 12 that the square of SSMD is Fisher's discrimination ratio. 13 If Fisher's discrimination ratio is used to measure effect size, it should belong to a class of metrics called variance-accounted-for effect sizes. As Hedges and Olkin 14 pointed out, variance-accounted-for effect sizes are intuitively appealing but are not well suited for combination across studies because these indices are inherently nondirectional and therefore can have the same value even though the research studies exhibit substantively different results. Therefore, SSMD is better than Fisher's discrimination ratio in measuring effect sizes even if one wants to use the latter to measure the size of siRNA effects.
Because SSMD can effectively measure the size of siRNA effects and its value is comparable across experiments, 4, 8, 10 we can use a value c 1 of SSMD to indicate large effects and another value c 2 of SSMD to indicate small effects. Based on both the original and probability meanings of SSMD, the values of interest for c 2 may be 0, 0.25, or 0.5, and those for c 1 may be 1.645, 2, 3, or 5 for SSMD across various HTS experiments. 8, 15 For selecting hits with positive effects, we may use the decision rule of declaring an siRNA as a hit if it haŝ b ≥ b * (whereb is an estimated SSMD value and b * is a cutoff) and as a nonhit otherwise. In this selection process, RFPR is the probability of selecting an siRNA with b ≤ c 2 as a hit-namely, PrðDeclare a hit given b ≤ c 2 Þ. Clearly, in this selection process, the smaller the b value, the smaller the RFPR; consequently, given b ≤ c 2 , the maximum of RFPR is achieved when b = c 2 . This maximal RFPR is called restricted false-positive level (RFPL). In other words, the upper limit of RFPR given b ≤ c 2 in a selection process is RFPL. 8 Similarly, FNR is the probability of not selecting an siRNA with b ≥ c 1 as a hit-namely, PrðNot declare a hit given b ≥ c 1 Þ. As an alternative to the control of error rates such as RFPR and FNR, we can control the power of selecting siRNAs with large effects as well as the power of excluding siRNAs with small or no effects. For convenience, let us call them ''power I'' and ''power II,'' respectively. For selecting siRNAs with positive effects, power I is the probability of selecting an siRNA with b ≥ c 1 as a hit-namely, PrðDeclare a hit given b ≥ c 1 Þ; power II is the probability of not selecting an siRNA with b ≤ c 2 as a hit-namely, PrðNot declare a hit given b ≤ c 2 Þ. Clearly, power I = 1-FNR and power II = 1-RFPR.
FNR and RFPR may also be linked to Type I and II error rates under certain conditions. To understand the differences and links between the concepts of FNR and RFPR and the concepts of Type I and II error rates, we need to explore the difference between classical hypothesis tests and the SSMD-based error control methods. Their major differences are briefly described as follows. First, the SSMD-based method focuses on the control of error rates related to intervals I1 and I3 in Figure 1B , whereas classical hypothesis tests aim at the control of error rates in intervals I1 and I2 in Figure 1A . Second, for the error control in the SSMD-based method, c 1 and c 2 are not fixed to a single value; instead, multiple meaningful values c 1 and c 2 for the parameter b are considered simultaneously. Third, the classical z-score method or t-test for hit selection usually aims at testing mean difference, fold change, percent viability, and so on, whereas SSMD-based error control methods aim at SSMD. The difference between these 2 methods of controlling error rates and the relationships among RFPR, FNR, Type I and II errors, and power is described in detail using statistical terminology in the appendix.
In the SSMD-based error control method, we simultaneously control RFPL with respect to (w.r.t) a c 2 value representing small effects and FNL w.r.t a c 1 value representing large effects. When c 2 and c 1 are both fixed, the RFPL and FNL are related to each other. In such a case, when one of them is under control, the other is also determined. However, in HTS experiments, we usually allow one or both of c 2 and c 1 to be changeable. For example, in one experiment focusing on the selection of siRNAs with extra large effects, we may fix c 1 to be 3, control the corresponding FNL to be 0.05, and then calculate the RFPL w.r.t. c 2 = 0; 0:25; 0:5, respectively.
If the RFPL w.r.t. c 2 = 0:25 is also small enough, we then control both FNL w.r.t. c 1 = 3 and RFPL w.r.t. c 2 = 0:25 to be preset low levels. In other experiments, we may control both FNL w.r.t. c 1 = 2 and RFPL w.r.t. c 2 = 0, both FNL w.r.t. c 1 = 3 and RFPL w.r.t. c 2 = 0, or both FNL w.r.t. c 1 = 2 and RFPL w.r.t. c 2 = 0:25 to be preset low levels. For a critical value of SSMD, we can also simultaneously explore RFPLs (or power II) w.r.t. multiple c 2 values and FNLs (or power I) w.r.t. multiple c 1 values. In the following 2 sections, we demonstrate how to control error rates and powers in genome-scale RNAi screens.
CONTROLLING ERROR RATES IN GENOME-SCALE RNAi SCREENS
To use the SSMD-based method for selecting hits in the direction of positive values in HTS assays, we need to search for a threshold b * for the estimated SSMDb so that we can maintain a balanced control of both RFPL and FNL when we use the decision rule of declaring an siRNA as a hit if it haŝ b ≥ b * and as a nonhit otherwise. The search for the decision rule relies on the distribution of SSMD estimates. When sample size is large, the estimate of SSMD has approximately a normal distribution. 4 Given b * , c 1 , and c 2 , we have
whereŝb can be calculated using the formulas provided in Zhang, 4 and Fð · Þ is the cumulative distribution function of the standard normal distribution. In a primary HTS experiment with no replicates for each siRNA, one approximated value forŝb is ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi
q when the number of sample wells in a plate is large (e.g., n 2 ≥ 100). When sample size is small, normal approximation cannot work effectively. However, we can use noncentral t-distribution to calculate RFPL and FNL, as described in Zhang.
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Given b * , c 1 , and c 2 , we have
where tðn; bbÞ is a noncentral t-distribution with n degrees of freedom, and noncentral parameter bb and F tðn, bbÞ · ð Þ is the cumulative distribution function of tðn; bbÞ. For an unpaired difference mainly in a primary screen,
≈ N − 3:48, N = n 1 + n 2 , and n 1 , X 1 , s 1 , n 2 , X 2 , and s 2 are sample size, mean, and standard deviation in 2 groups,
Based on formulas (1) to (4), we can calculate theoretical RFPL and FNL corresponding to each set of values for b * , c 1 , and c 2 . In a primary screen, the majority of sample wells may be used as the negative reference in a plate. In such a case, n 2 is about 300, and thus the error rates obtained using normal approximation are essentially the same as those obtained using noncentral t-distribution. Hence, to select hits in the direction of positive values, we may use normal approximation shown in formulas (1) and (2) capacity of follow-up studies after that experiment. For example, if one has a low tolerance in missing hits with SSMD greater than 2 or 3 (or less than -2 or -3), one may choose a critical value between 1.4 and 1.6 (or between -1.6 and -1.4).
On the other hand, if follow-up studies have a low capacity of including selected hits, one may choose a critical value between 1.8 and 2.1 (or between -2.1 and -1.8). These critical values may maintain a balanced control of both RFPR for including siRNAs with small or no effects and FNR for excluding siRNAs with large effects. It should be noted that the normal approximation usually works effectively in a primary screen as long as the number of sample wells is large and the assumption of equal variance holds. In a confirmatory screen with replicates, to incorporate information across replicates, researchers commonly use paired differences for hit selection. In such a case, the SSMD
where n, D, and S D are sample size (i.e., number of replicates for each siRNA), sample mean, and standard deviation of a paired difference, respec-
Because n is small (usually 2 to 4), normal approximation cannot work effectively. Details about hit selection in confirmatory screens can be referenced in Zhang.
In real experiments where both a negative control and a positive control are available, we may calculate empirical or practical RFPR or FNR based on the negative and positive controls. In the mucin RNAi HTS experiment described in Zhang et al., 9 there is 1 negative control and 1 inhibition control. We use the inhibition control to calculate empirical FNR as follows: for a given cutoff b * , the empirical FNR is the proportion of wells for the inhibition control withb < b * . The resulting empirical FNRs are shown using the dashed black line in Figure 2A . Similarly, we can use the negative control to calculate empirical RFPR with the results shown by the solid black line in Figure 2B . The empirical FNR curve for the inhibition control lies between the theoretical FNL curves w.r.t. c 1 = 3 and c 1 = 4.7, respectively, and very close to the theoretical FNL curves w.r.t. c 1 = 3 ( Fig. 2A) , which indicates that the inhibition control has a theoretical SSMD value slightly above 3. The empirical RFPR curve for the negative control crosses over 3 theoretical RFPL curves w.r.t. c 2 = 0,-0.25, and -0.5, respectively (Fig. 2B) , which indicates that the negative control has unstable activation effects. Because the effect of this negative control is not stable, whereas the effect of the inhibition control is stable, we may not use the empirical RFPR w.r.t the negative control but only use the FNR w.r.t. the inhibition control for selecting hits in the mucin screen. To control the probability of missing siRNAs with strong effects similar to the inhibition control being under 0.025, we may set the critical value b * to be 1.614, which leads to the selection of 871 inhibition hits. The theoretical error rates corresponding to 
FIG. 2. Error rates in a primary mucin RNAi high-throughput screen (HTS)
. Panels A and B show error rates, including both false-negative level (FNL) and restricted false-positive level (RFPL) for selecting inhibition hits and activation hits, respectively. this critical value are 0.011 for RFPL w.r.t c 2 = 0, 0.027 for RFPL w.r.t c 2 = 0.25, 0.058 for RFPL w.r.t c 2 = 0.5, 0.293 for FNL w.r.t c 1 = 2, 0.025 for FNL w.r.t c 1 = 3, and 0.0000003 for FNL w.r.t c 1 = 5. Considering no activation control in the mucin screen, we may accordingly use a critical value of -1.614 for selecting activation hits, which leads to the selection of 17 activation hits.
CONTROLLING POWERS IN GENOME-SCALE RNAi SCREENS
For hit selection in RNAi HTS assays, we need to determine a decision rule corresponding to a critical value b * so that we do not miss siRNAs with large effects while not including siRNAs with no or small effects. As described above, one way to achieve this dual goal is to control both FNR and RFPR. As an alternative, we may control both the power of selecting siRNAs with large effects and the power of avoiding siRNAs with no or small effects. Traditional power function is the plot of power versus possible true value of b. However, our interest in hit selection is to determine a critical value or cutoff for selecting effective siRNAs. To search a critical value for selecting effective siRNAs, we need to first plot power versus critical value b * , not b, and then find the value of b * that achieves a desired power. Clearly, traditional power function (including the power curves displayed in Schechtman 12 ) works neither effectively nor directly in searching b * for selecting effective siRNAs. If we fix b, we can get the plot of power versus b * . For example, if one needs to select siRNAs with positive effects, the minimal power for selecting siRNAs with b ≥ c 1 corresponding to a critical value b * (i.e., power I) is
for a fixed c 1 . In this situation, our interest is a large value for the powers corresponding to c 1 = 2; 3; 5; a large value for empirical power of the inhibition control (solid curves in for a fixed c 2 . In this case, our interest is a large value for the powers corresponding to c 2 = 0; 0:25; 0:5; a large value for the empirical power of the negative control (solid curves in Fig. 3C) ; and a small value for the powers corresponding to large values of c 2 , such as 2, 3, and 5 (dashed curves in Fig.  3C ). Any critical value b * between 1.4 and 2.1 can lead to the power for selecting siRNAs with SSMD ≤ 0-namely, no inhibition effect (or SSMD ≤ 0.25-namely, small effect) to be greater than 0.975 (or 0.95).
In the mucin screen, corresponding to the critical value of b * = 1.614 for inhibition hits, the powers for selecting siRNAs with SSMD ≥ 2, 3, and 5 are greater than 0.717, 0.975, and 0.9999999, respectively (Fig. 3A) . Meanwhile, the powers for avoiding siRNAs with SSMD ≤ 0, 0.25, and 0.5 are greater than 0.989, 0.973, and 0.942, respectively (Fig. 3C) . Similarly, as we calculate the power for selecting inhibition hits, we can calculate the power for selecting activation hits-namely, the powers for selecting siRNAs with SSMD ≤ -2, -3, and -4.7 (Fig. 3B) and the powers for avoiding siRNAs with SSMD ≥ 0, -0.25, and -0.5 (Fig. 3D) .
DISCUSSION
In genome-scale RNAi research, hit selection is a vital process that requires the development and adoption of appropriate analytic methods 7, [16] [17] [18] [19] [20] For hit selection in RNAi HTS assays, there is a need to control both FNR and RFPR. The SSMD-based method fills such a need. When c 2 or c 1 is fixed, RFPL in SSMD-based error control method may be interpreted as either a Type I or II error level in a classical hypothesis test, depending on the preset hypotheses. However, as shown in the appendix, RFPL is not the same as either Type I or II error level. FNR is linked to the power of selecting siRNAs with large effects as hits, and RFPR is linked to the power of excluding siRNAs with no or small effects in the list of selected hits.
As an alternative to the error control method, we may use these 2 types of powers to determine a critical value of SSMD for hit selection in RNAi HTS assays. We demonstrate how to use an SSMD-based error control method (Fig. 2) and power method (Fig. 3) to select hits in a mucin primary RNAi HTS screen. When 2 types of powers are considered simultaneously as in Figure 3A , C, for a large SSMD true value, we want a high power of keeping siRNAs with strong effects; meanwhile, for a small SSMD true value, we want a high power of avoiding siRNAs with no or small effects. In other words, what we want is a large value for both types of powers. Alternatively, we can use only one type of power. In such a case, we may need a large power value in some cases and a small power value in other cases. For example, when we use only the power of keeping siRNAs with large effects, what we want is a high power value for large SSMD true value and a small power value for small SSMD true value, as shown by the solid and dashed curves in Figure 2A , respectively.
It should be noted that, to search for a critical value that achieves a desired power, we plot power versus critical value b * for the estimated SSMD values. This power curve is different from a traditional power curve. A traditional power curve is the plot of power versus possible true value of SSMD b, not critical value b * . Thus, traditional power function works neither effectively nor directly in searching a critical value b * for selecting effective siRNAs. Finally, although the error (or power) control methods described in this article are applied to a statistical parameter SSMD, they may be applied to any statistical parameter (such as standardized mean of contrast 15 ) that has the following 2 properties: (1) it can effectively assess the size of siRNA effects, and (2) its values are comparable across various RNAi HTS experiments.
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APPENDIX
Hypothesis test and SSMD-based error control method
In a classical hypothesis test, there are 2 hypotheses: a null hypothesis H 0 and an alternative hypothesis H a . The alternative hypothesis is the complement of the null hypothesis. For These hypothesis tests focus on testing a fixed value c for b as illustrated in Figure 1A . Type I error rate is the probability of rejecting H 0 when H 0 is correct (or given the true value falling in H 0 ), and Type II error rate is the probability of not rejecting H 0 when H a is correct. The power of a test is the probability of rejecting H 0 when H a is correct. 
Thus, once Type I error level is set to be a, then the Type II error level is determined to be 1 − a. That is why it is impossible to control both Type I and II error levels simultaneously in a classical test for a given data set. By contrast, for the error control in the SSMD-based method, c 1 and c 2 are not fixed to a single value (Fig. 1B) ; instead, multiple meaningful values c 1 are under control. In other words, the core idea is to select a set of values for (b * , c 1 , c 2 ) such that both Prðb ≥ b * |b ≤ c 2 Þ
and Prðb < b * |b ≥ c 1 Þ are reasonably low. The rationale behind this approach is the consideration of 2 major concerns in the process of selecting the siRNAs with a large effect in RNAi HTS experiments. First, we do not want the siRNAs with large effects to be selected as nonhits. Second, we do not want the siRNAs with small effects to be selected as hits. The probabilities PrðDeclare a hit |b ≤ c 2 Þ and PrðNot declare a hit |b ≥ c 1 Þ are RFPR and FNR, respectively; their upper limits are restricted false-positive level (RFPL) and false-negative level (FNL), respectively. 8 When c 1 = c 2 , RFPR becomes the classical false-positive rate, and RFPL becomes the classical false-positive level.
RFPR, FNR, and Type I and II errors
In the SSMD-based method for maintaining a balanced control of both RFPR and FNR, c 1 and c 2 are not fixed to a single value. To search a decision rule for hit selection, one should, given a critical value, calculate RFPLs w.r.t. certain meaningful c 2 s using formula (1) or (3) and FNLs w.r.t. certain meaningful c 1 s using formula (2) or (4). This approach has been illustrated in 
On the other hand, given c 2 and RFPL, we can search b * , c 1 ,
and FNL using
The reason why we can let the search begin with either c 1 or c 2 is because the intervals I1 and I3 (specified by c 2 and c 1 , respectively) shown in Figure 1 are treated equally in the SSMD-based method. Similar to formulas (A3) to (A6), the following formulas can be obtained when sample size is small, such as in a confirmatory screen. 
